Larvol Delta - AmMax-Bios-AMB05X-Receives-EMA-PRIME-Designation-for-the-Treatment-of-Tenosynovial-Giant-Cell-Tumor-TGCT

AMB-05X - AmMax

https://www.globenewswire.com/news-release/2023/01/19/2592112/0/en/AmMax-Bio-s-AMB-05X-Receives-EMA-PRIME-Designation-for-the-Treatment-of-Tenosynovial-Giant-Cell-Tumor-TGCT.html

Jan 19, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next